Healthy Extracts Inc. (HYEX)
OTC PINK OTC PINK Primary 
Healthy Extracts Expects 2024 Net Revenue Up 24%, Driving Positive Cash Flow
Results Driven by 80% Growth in Subscription-Based Recurring Revenue, Strengthening Customer Retention and Lifetime Value (LTV) LAS VEGAS, NV / ACCESSWIRE / January 14, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), an innovative platform for acquiring, developing, patenting, marketing and distributing plant-based nutraceuticals, expects to report record results for the year ended December 31, 2024. For full year 2024, net revenue is expected to exceed a record $3.1 million, up 24% year-over-year.
Healthy Extracts Reports Record Q3 2024; Issues Guidance for 20%+ Growth and Positive Cash Flow for Full Year 2024
Net revenue up 21% year-over-year to record third-quarter high. Achieved fourth consecutive positive cash flow quarter while still investing in future growth.
Healthy Extracts Expects to Report Record Third Quarter 2024, with Net Revenue Up More than 20%
Strong Growth in Subscription-Based Recurring Revenue Continues for Healthy Extracts as Category Top Three Amazon Seller LAS VEGAS, NV / ACCESSWIRE / October 17, 2024 / Healthy Extracts Inc. (OTCQB:HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported preliminary record results for the third quarter ended September 30, 2024. Net revenue is expected to exceed $740,000, a record for a third quarter, up more than 20% compared to the same year-ago quarter.
Healthy Extracts Reports Q2 2024 Net Revenue Up 54% to Record High, Driving Positive EPS
Strong Subscription-Based Revenue Growth and Third Sequential Positive Cash Flow Quarter LAS VEGAS, NV / ACCESSWIRE / August 14, 2024 / Healthy Extracts Inc. (OTCQB:HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported results for the three and six months ended June 30, 2024. All comparisons are to the same year-ago period unless otherwise noted.
